{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:27:23Z","timestamp":1790652443329,"version":"4.1.0"},"reference-count":144,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>The S100 protein is one of the calcium-binding proteins associated with Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis. S100 proteins are expressed in the central nervous system by oligodendrocytes, astrocytes and neurons during both normal and disease conditions. Although amyloid-beta aggregation and hyperphosphorylated tau plaques are the main pathological hallmarks of Alzheimer\u2019s disease, the S100 protein family is closely associated with neuroinflammation in several neurodegenerative disorders, such as Alzheimer\u2019s disease, Parkinson\u2019s disease, amyotrophic lateral sclerosis in addition to various types of cancer and other brain diseases. This review aims to present the key role of S100 proteins and their different relevant isoforms, along with the various approaches used for the regulation of these proteins in several neurodegenerative disorders.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871527322666221128160653","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T05:53:42Z","timestamp":1669701222000},"page":"1403-1416","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders"],"prefix":"10.2174","volume":"22","author":[{"given":"Deepali","family":"Goswami","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Transit Campus, Bijnour-Sisendi Road, Sarojini Nagar, Lucknow-226002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urati","family":"Anuradha","sequence":"additional","affiliation":[{"name":"Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli. Transit Campus, Bijnour-Sisendi Road, Sarojini Nagar, Lucknow-226002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anok","family":"Angati","sequence":"additional","affiliation":[{"name":"Department of Regulatory Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli. Transit Campus, Bijnour-Sisendi Road, Sarojini Nagar, Lucknow-226002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Transit Campus, Bijnour-Sisendi Road, Sarojini Nagar, Lucknow-226002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, Transit Campus, Bijnour-Sisendi Road, Sarojini Nagar, Lucknow-226002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/35036035","volume":"1","author":"Berridge M.J.","year":"2000","unstructured":"Berridge M.J.; Lipp P.; Bootman M.D.; The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000,1(1),11-21","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/10409238009105467","volume":"8","author":"Kretsinger R.H.","year":"1980","unstructured":"Kretsinger R.H.; Wasserman R.H.; Structure and evolution of calcium-modulated proteins. Crit Rev Biochem 1980,8(2),119-174","journal-title":"Crit Rev Biochem"},{"key":"ref=3","first-page":"276","volume":"61","author":"Yardan T.","year":"2011","unstructured":"Yardan T.; Erenler A.K.; Baydin A.; Aydin K.; Cokluk C.; Usefulness of S100B protein in neurological disorders. J Pak Med Assoc 2011,61(3),276-281","journal-title":"J Pak Med Assoc"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2174\/1570159X18666200729100427","volume":"19","author":"Langeh U.","year":"2020","unstructured":"Langeh U.; Singh S.; Targeting S100B protein as a surrogate biomarker and its role in various neurological disorders. Curr Neuropharmacol 2020,19(2),265-277","journal-title":"Curr Neuropharmacol"},{"key":"ref=5","first-page":"319","volume":"72","author":"Lodeiro M.","year":"2017","unstructured":"Lodeiro M.; Puerta E.; Ismail M.A.; Aggregation of the inflammatory s100a8 precedes a\u03b2 plaque formation in transgenic app mice: positive feedback for s100a8 and a\u03b2 productions. J Gerontol A Biol Sci Med Sci 2017,72(3),319-328","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.bbamcr.2018.10.015","volume":"1866","author":"Heizmann C.W.","year":"2019","unstructured":"Heizmann C.W.; S100 proteins: Diagnostic and prognostic biomarkers in laboratory medicine. Biochim Biophys Acta Mol Cell Res 2019,1866(7),1197-1206","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/bs.acc.2020.02.006","volume":"98","author":"Sreejit G.","year":"2020","unstructured":"Sreejit G.; Flynn M.C.; Patil M.; Krishnamurthy P.; Murphy A.J.; Nagareddy P.R.; S100 family proteins in inflammation and beyond. Adv Clin Chem 2020,98,173-231","journal-title":"Adv Clin Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(97)00701-5","volume":"235","author":"Green A.J.E.","year":"1997","unstructured":"Green A.J.E.; Harvey R.J.; Thompson E.J.; Rossor M.N.; Increased S100\u03b2 in the cerebrospinal fluid of patients with frontotemporal dementia. Neurosci Lett 1997,235(1-2),5-8","journal-title":"Neurosci Lett"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/jmri.1880070620","volume":"7","author":"Fox N.C.","year":"1997","unstructured":"Fox N.C.; Freeborough P.A.; Brain atrophy progression measured from registered serial MRI: Validation and application to alzheimer\u2019s disease. J Magn Reson Imaging 1997,7(6),1069-1075","journal-title":"J Magn Reson Imaging"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/0169-328X(95)00145-I","volume":"34","author":"Pe\u00f1a L.A.","year":"1995","unstructured":"Pe\u00f1a L.A.; Brecher C.W.; Marshak D.R.; \u03b2-Amyloid regulates gene expression of glial trophic substance S100\u03b2 in C6 glioma and primary astrocyte cultures. Brain Res Mol Brain Res 1995,34(1),118-126","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2202-8-2","volume":"8","author":"Steiner J.","year":"2007","unstructured":"Steiner J.; Bernstein H.G.; Bielau H.; Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci 2007,8(1),2","journal-title":"BMC Neurosci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"Donato R.","year":"2001","unstructured":"Donato R.; S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001,33(7),637-668","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/jemt.10303","volume":"60","author":"Rothermundt M.","year":"2003","unstructured":"Rothermundt M.; Peters M.; Prehn J.H.M.; Arolt V.; S100B in brain damage and neurodegeneration. Microsc Res Tech 2003,60(6),614-632","journal-title":"Microsc Res Tech"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jnr.490390406","volume":"39","author":"Sheng J.G.","year":"1994","unstructured":"Sheng J.G.; Mrak R.E.; Griffin W.S.T.; S100? protein expression in Alzheimer disease: Potential role in the pathogenesis of neuritic plaques. J Neurosci Res 1994,39(4),398-404","journal-title":"J Neurosci Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1742-2094-7-78","volume":"7","author":"Roltsch E.","year":"2010","unstructured":"Roltsch E.; Holcomb L.; Young K.A.; Marks A.; Zimmer D.B.; PSAPP mice exhibit regionally selective reductions in gliosis and plaque dep-osition in response to S100B ablation. J Neuroinflammation 2010,7(1),78","journal-title":"J Neuroinflammation"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/glia.20924","volume":"58","author":"Mori T.","year":"2010","unstructured":"Mori T.; Koyama N.; Arendash G.W.; Horikoshi-Sakuraba Y.; Tan J.; Town T.; Overexpression of human S100B exacerbates cerebral amy-loidosis and gliosis in the Tg2576 mouse model of Alzheimer\u2019s disease. Glia 2010,58(3),300-314","journal-title":"Glia"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbamcr.2004.09.011","volume":"1742","author":"Boom A.","year":"2004","unstructured":"Boom A.; Pochet R.; Authelet M.; Astrocytic calcium\/zinc binding protein S100A6 over expression in Alzheimer\u2019s disease and in PS1\/APP transgenic mice models. Biochim Biophys Acta Mol Cell Res 2004,1742(1-3),161-168","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3233\/JAD-150745","volume":"50","author":"Weissmann R.","year":"2016","unstructured":"Weissmann R.; H\u00fcttenrauch M.; Kacprowski T.; Gene expression profiling in the APP\/PS1KI mouse model of familial Alzheimer\u2019s Disease. J Alzheimers Dis 2016,50(2),397-409","journal-title":"J Alzheimers Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"13462","DOI":"10.1016\/S0021-9258(18)98862-9","volume":"266","author":"Teigelkamp S.","year":"1991","unstructured":"Teigelkamp S.; Bhardwaj R.S.; Roth J.; Meinardus-Hager G.; Karas M.; Sorg C.; Calcium-dependent complex assembly of the myeloic differ-entiation proteins MRP-8 and MRP-14. J Biol Chem 1991,266(20),13462-13467","journal-title":"J Biol Chem"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004183","volume":"4","author":"Qin W.","year":"2009","unstructured":"Qin W.; Ho L.; Wang J.; Peskind E.; Pasinetti G.M.; S100A7, a novel Alzheimer\u2019s disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10. PLoS One 2009,4(1)","journal-title":"PLoS One"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2868373","volume":"2020","author":"Carvalho A.","year":"2020","unstructured":"Carvalho A.; Lu J.; Francis J.D.; S100A12 in Digestive Diseases and Health: A Scoping Review. Gastroenterol Res Pract 2020,2020,1-11","journal-title":"Gastroenterol Res Pract"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1023\/A:1020700117665","volume":"24","author":"Heizmann C.W.","year":"1999","unstructured":"Heizmann C.W.; Ca2+-binding S100 proteins in the central nervous system. Neurochem Res 1999,24(9),1097-1100","journal-title":"Neurochem Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-1-62703-230-8_23","volume":"963","author":"Astrand R.","year":"2013","unstructured":"Astrand R.; Und\u00e9n J.; Romner B.; Clinical use of the calcium-binding S100B protein. Methods Mol Biol 2013,963,373-384","journal-title":"Methods Mol Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/0006-291X(65)90320-7","volume":"19","author":"Moore B.W.","year":"1965","unstructured":"Moore B.W.; A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965,19(6),739-744","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1432-1033.1981.tb05303.x","volume":"116","author":"Isobe T.","year":"1981","unstructured":"Isobe T.; Okuyama T.; The amino-acid sequence of the alpha subunit in bovine brain S-100a protein. Eur J Biochem 1981,116(1),79-86","journal-title":"Eur J Biochem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1432-1033.1978.tb12539.x","volume":"89","author":"Isobe T.","year":"1978","unstructured":"Isobe T.; Okuyama T.; The amino-acid sequence of S-100 protein (PAP I-b protein) and its relation to the calcium-binding proteins. Eur J Biochem 1978,89(2),379-388","journal-title":"Eur J Biochem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/0361-9230(95)00040-2","volume":"37","author":"Zimmer D.B.","year":"1995","unstructured":"Zimmer D.B.; Cornwall E.H.; Landar A.; Song W.; The S100 protein family: History, function, and expression. Brain Res Bull 1995,37(4),417-429","journal-title":"Brain Res Bull"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1515\/CCLM.2011.083","volume":"49","author":"Steiner J.","year":"2011","unstructured":"Steiner J.; Bogerts B.; Schroeter M.L.; Bernstein H.G.; S100B protein in neurodegenerative disorders. Clin Chem Lab Med 2011,49(3),409-424","journal-title":"Clin Chem Lab Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.bbamcr.2008.11.016","volume":"1793","author":"Leclerc E.","year":"2009","unstructured":"Leclerc E.; Fritz G.; Vetter S.W.; Heizmann C.W.; Binding of S100 proteins to RAGE: An update. Biochim Biophys Acta Mol Cell Res 2009,1793(6),993-1007","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=30","first-page":"d1356","volume":"7","author":"Heizmann C.W.","year":"2002","unstructured":"Heizmann C.W.; Fritz G.; Sch\u00e4fer B.W.; S100 proteins: structure, functions and pathology. Front Biosci: J Virtual Librar 2002,7,d1356-d1368","journal-title":"Front Biosci: J Virtual Librar"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0167-4889(99)00058-0","volume":"1450","author":"Donato R.","year":"1999","unstructured":"Donato R.; Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type. Biochim Biophys Acta Mol Cell Res 1999,1450(3),191-231","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1021\/bi0118052","volume":"41","author":"Ferguson P.L.","year":"2002","unstructured":"Ferguson P.L.; Shaw G.S.; Role of the N-terminal helix I for dimerization and stability of the calcium-binding protein S100B. Biochemistry 2002,41(11),3637-3646","journal-title":"Biochemistry"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neubiorev.2021.04.035","volume":"127","author":"Michetti F.","year":"2021","unstructured":"Michetti F.; Di Sante G.; Clementi M.E.; Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders. Neurosci Biobehav Rev 2021,127,446-458","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=34","first-page":"13","author":"Donato R.","year":"2012","unstructured":"Donato R.; Cannon B.; Sorci G.; Riuzzi F.; Hsu K.; Weber D.; Functions of S100 proteins. Curr Mol Med 2012,13","journal-title":"Curr Mol Med"},{"key":"ref=35","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/687067","volume":"2010","author":"Mori T.","year":"2010","unstructured":"Mori T.; Asano T.; Town T.; Targeting S100B in cerebral ischemia and in Alzheimer\u2019s disease. Cardiovasc Psychiatry Neurol 2010,2010","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.bbrc.2004.07.096","volume":"322","author":"Marenholz I.","year":"2004","unstructured":"Marenholz I.; Heizmann C.W.; Fritz G.; S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004,322(4),1111-1122","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=37","first-page":"1282","volume":"1763","author":"Marenholz I.","year":"2006","unstructured":"Marenholz I.; Lovering R.C.; Heizmann C.W.; An update of the S100 nomenclature. Biochimica et Biophysica Acta (BBA) -. Molecular Cell Research 2006,1763(11),1282-1283","journal-title":"Molecular Cell Research"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.biochi.2011.05.028","volume":"93","author":"Kizawa K.","year":"2011","unstructured":"Kizawa K.; Takahara H.; Unno M.; Heizmann C.W.; S100 and S100 fused-type protein families in epidermal maturation with special focus on S100A3 in mammalian hair cuticles. Biochimie 2011,93(12),2038-2047","journal-title":"Biochimie"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3389\/fimmu.2017.01908","volume":"8","author":"Xia C.","year":"2018","unstructured":"Xia C.; Braunstein Z.; Toomey A.C.; Zhong J.; Rao X.; S100 proteins as an important regulator of macrophage inflammation. Front Immunol 2018,8,1908","journal-title":"Front Immunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1074\/jbc.M406440200","volume":"280","author":"Arcuri C.","year":"2005","unstructured":"Arcuri C.; Bianchi R.; Brozzi F.; Donato R.; S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation. J Biol Chem 2005,280(6),4402-4414","journal-title":"J Biol Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1042\/BJ20060195","volume":"396","author":"Santamaria-Kisiel L.","year":"2006","unstructured":"Santamaria-Kisiel L.; Rintala-Dempsey A.C.; Shaw G.S.; Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 2006,396(2),201-214","journal-title":"Biochem J"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0197-4580(01)00293-7","volume":"22","author":"Mrak R.","year":"2001","unstructured":"Mrak R.; Griffinbc W.S.; The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer\u2019s dis-ease. Neurobiol Aging 2001,22(6),915-922","journal-title":"Neurobiol Aging"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jneuroim.2008.10.012","volume":"206","author":"de Souza D.F.","year":"2009","unstructured":"de Souza D.F.; Leite M.C.; Quincozes-Santos A.; S100B secretion is stimulated by IL-1\u03b2 in glial cultures and hippocampal slices of rats: Likely involvement of MAPK pathway. J Neuroimmunol 2009,206(1-2),52-57","journal-title":"J Neuroimmunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s11064-009-9949-0","volume":"34","author":"Nardin P.","year":"2009","unstructured":"Nardin P.; Tortorelli L.; Quincozes-Santos A.; S100B secretion in acute brain slices: modulation by extracellular levels of Ca(2+) and K.(+) Neurochem Res 2009,34(9),1603-1611","journal-title":"Neurochem Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.pnpbp.2008.06.001","volume":"32","author":"Tramontina A.C.","year":"2008","unstructured":"Tramontina A.C.; Tramontina F.; Bobermin L.D.; Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Prog Neuropsychopharmacol Biol Psychiatry 2008,32(6),1580-1583","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","volume":"1793","author":"Donato R.","year":"2009","unstructured":"Donato R.; Sorci G.; Riuzzi F.; S100B\u2019s double life: Intracellular regulator and extracellular signal. Biochim Biophys Acta Mol Cell Res 2009,1793(6),1008-1022","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=47","first-page":"198","volume":"12","author":"Sedaghat F.","year":"2008","unstructured":"Sedaghat F.; Notopoulos A.; S100 protein family and its application in clinical practice. Hippokratia 2008,12(4),198-204","journal-title":"Hippokratia"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.clinbiochem.2004.05.012","volume":"37","author":"Harpio R.","year":"2004","unstructured":"Harpio R.; Einarsson R.; S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. Clin Biochem 2004,37(7),512-518","journal-title":"Clin Biochem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","volume":"135","author":"Sathe K.","year":"2012","unstructured":"Sathe K.; Maetzler W.; Lang J.D.; S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-\u03b1 pathway. Brain 2012,135(11),3336-3347","journal-title":"Brain"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"Hofmann M.A.","year":"1999","unstructured":"Hofmann M.A.; Drury S.; Fu C.; RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100\/] calgranulin polypeptides. Cell 1999,97(7),889-901","journal-title":"Cell"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fnins.2019.00463","volume":"13","author":"Crist\u00f3v\u00e3o J.S.","year":"2019","unstructured":"Crist\u00f3v\u00e3o J.S.; Gomes C.M.; S100 Proteins in Alzheimer\u2019s Disease. Front Neurosci 2019,13,463","journal-title":"Front Neurosci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/978-1-61779-551-0_25","volume":"849","author":"Botelho H.M.","year":"2012","unstructured":"Botelho H.M.; Fritz G.; Gomes C.M.; Analysis of S100 oligomers and amyloids. Methods Mol Biol 2012,849,373-386","journal-title":"Methods Mol Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jnr.20785","volume":"83","author":"Businaro R.","year":"2006","unstructured":"Businaro R.; Leone S.; Fabrizi C.; S100B protects LAN-5 neuroblastoma cells against A\u03b2 amyloid-induced neurotoxicity via RAGE engagement at low doses but increases A\u03b2 amyloid neurotoxicity at high doses. J Neurosci Res 2006,83(5),897-906","journal-title":"J Neurosci Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","volume":"3","author":"LaFerla F.M.","year":"2002","unstructured":"LaFerla F.M.; Calcium dyshomeostasis and intracellular signalling in alzheimer\u2019s disease. Nat Rev Neurosci 2002,3(11),862-872","journal-title":"Nat Rev Neurosci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","volume":"1842","author":"Wang X.","year":"2014","unstructured":"Wang X.; Wang W.; Li L.; Perry G.; Lee H.; Zhu X.; Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 2014,1842(8),1240-1247","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1006\/excr.2000.4902","volume":"257","author":"Xiong Z.","year":"2000","unstructured":"Xiong Z.; O\u2019Hanlon D.; Becker L.E.; Roder J.; MacDonald J.F.; Marks A.; Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp Cell Res 2000,257(2),281-289","journal-title":"Exp Cell Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"Masters C.L.","year":"2015","unstructured":"Masters C.L.; Bateman R.; Blennow K.; Rowe C.C.; Sperling R.A.; Cummings J.L.; Alzheimer\u2019s disease. Nat Rev Dis Primers 2015,1(1),15056","journal-title":"Nat Rev Dis Primers"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nri1843","volume":"6","author":"Weiner H.L.","year":"2006","unstructured":"Weiner H.L.; Frenkel D.; Immunology and immunotherapy of Alzheimer\u2019s disease. Nat Rev Immunol 2006,6(5),404-416","journal-title":"Nat Rev Immunol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/jnr.21211","volume":"85","author":"Sen J.","year":"2007","unstructured":"Sen J.; Belli A.; S100B in neuropathologic states: The CRP of the brain? J Neurosci Res 2007,85(7),1373-1380","journal-title":"J Neurosci Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0304-3940(02)01257-0","volume":"336","author":"Petzold A.","year":"2003","unstructured":"Petzold A.; Jenkins R.; Watt H.C.; Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer\u2019s disease. Neurosci Lett 2003,336(3),167-170","journal-title":"Neurosci Lett"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1468-1331.2006.01667.x","volume":"14","author":"Wilhelm K.R.","year":"2007","unstructured":"Wilhelm K.R.; Yanamandra K.; Gruden M.A.; Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Par-kinson\u2019s disease patients. Eur J Neurol 2007,14(3),327-334","journal-title":"Eur J Neurol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/539581","volume":"2010","author":"Leclerc E.","year":"2010","unstructured":"Leclerc E.; Sturchler E.; Vetter S.W.; The S100B\/RAGE Axis in Alzheimer\u2019s Disease. Cardiovasc Psychiatry Neurol 2010,2010,1-11","journal-title":"Cardiovasc Psychiatry Neurol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","volume":"10","author":"Gonz\u00e1lez-Reyes R.E.","year":"2017","unstructured":"Gonz\u00e1lez-Reyes R.E.; Nava-Mesa M.O.; Vargas-S\u00e1nchez K.; Ariza-Salamanca D.; Mora-Mu\u00f1oz L.; Involvement of astrocytes in alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective. Front Mol Neurosci 2017,10,427","journal-title":"Front Mol Neurosci"},{"key":"ref=64","first-page":"201-14","volume":"51","author":"Zimmer DB","year":"2005","unstructured":"Zimmer DB; Chaplin J; Baldwin A; Rast M; S100-mediated signal transduction in the nervous system and neurological diseases Cellular and molecular biology (Noisy-le-Grand, France) 2005,51(2),201-14","journal-title":"S100-mediated signal transduction in the nervous system and neurological diseases Cellular and molecular biology (Noisy-le-Grand, France)"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000333781","volume":"10","author":"Chang K.A.","year":"2012","unstructured":"Chang K.A.; Kim H.J.; Suh Y.H.; The role of S100a9 in the pathogenesis of Alzheimer\u2019s disease: the therapeutic effects of S100a9 knock-down or knockout. Neurodegener Dis 2012,10(1-4),27-29","journal-title":"Neurodegener Dis"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3892\/or.2017.5922","volume":"38","author":"Wu L.","year":"2017","unstructured":"Wu L.; Zhou X.; Xiao Z.; Functional expression, characterization, and application of human S100B. Oncol Rep 2017,38(4),2309-2316","journal-title":"Oncol Rep"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00018-020-03673-x","volume":"78","author":"Angelopoulou E.","year":"2021","unstructured":"Angelopoulou E.; Paudel Y.N.; Piperi C.; Emerging role of S100B protein implication in Parkinson\u2019s disease pathogenesis. Cell Mol Life Sci 2021,78(4),1445-1453","journal-title":"Cell Mol Life Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/glia.10225","volume":"42","author":"Muramatsu Y.","year":"2003","unstructured":"Muramatsu Y.; Kurosaki R.; Watanabe H.; Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 2003,42(3),307-313","journal-title":"Glia"},{"key":"ref=69","first-page":"419","volume":"6","author":"Isobe T.","year":"1983","unstructured":"Isobe T.; Ishioka N.; Masuda T.; Takahashi Y.; Ganno S.; Okuyama T.; A rapid separation of S100 subunits by high performance liquid chromatography: the subunit compositions of S100 proteins. Biochem Int 1983,6(3),419-426","journal-title":"Biochem Int"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jnc.14574","volume":"148","author":"Michetti F.","year":"2019","unstructured":"Michetti F.; D\u2019Ambrosi N.; Toesca A.; The S100B story: from biomarker to active factor in neural injury. J Neurochem 2019,148(2),168-187","journal-title":"J Neurochem"},{"key":"ref=71","first-page":"40096-105","volume":"275","author":"Huttunen HJ","year":"2000","unstructured":"Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. 2000,275(51),40096-105"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1073\/pnas.88.9.3554","volume":"88","author":"Selinfreund R.H.","year":"1991","unstructured":"Selinfreund R.H.; Barger S.W.; Pledger W.J.; Van Eldik L.J.; Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc Natl Acad Sci 1991,88(9),3554-3558","journal-title":"Proc Natl Acad Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fnmol.2017.00456","volume":"10","author":"Hagmeyer S.","year":"2018","unstructured":"Hagmeyer S.; Crist\u00f3v\u00e3o J.S.; Mulvihill J.J.E.; Boeckers T.M.; Gomes C.M.; Grabrucker A.M.; Zinc binding to S100B affords regulation of trace metal homeostasis and excitotoxicity in the brain. Front Mol Neurosci 2018,10,456","journal-title":"Front Mol Neurosci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1016\/S0021-9258(18)60647-7","volume":"263","author":"Baudier J.","year":"1988","unstructured":"Baudier J.; Cole R.D.; Interactions between the microtubule-associated tau proteins and S100b regulate tau phosphorylation by the Ca2+\/calmodulin-dependent protein kinase II. J Biol Chem 1988,263(12),5876-5883","journal-title":"J Biol Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0143-4160(96)90033-0","volume":"20","author":"Landar A.","year":"1996","unstructured":"Landar A.; Caddell G.; Chessher J.; Zimmer D.B.; Identification of an S100A1\/S100B target protein: phosphoglucomutase. Cell Calcium 1996,20(3),279-285","journal-title":"Cell Calcium"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"11424","DOI":"10.1016\/S0021-9258(18)67402-2","volume":"261","author":"Zimmer D.B.","year":"1986","unstructured":"Zimmer D.B.; Van Eldik L.J.; Identification of a molecular target for the calcium-modulated protein S100. Fructose-1,6-bisphosphate al-dolase. J Biol Chem 1986,261(24),11424-11428","journal-title":"J Biol Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1053\/jcan.2000.18444","volume":"14","author":"J\u00f6nsson H.","year":"2000","unstructured":"J\u00f6nsson H.; Johnsson P.; H\u00f6glund P.; Alling C.; Blomquist S.; Elimination of S100B and renal function after cardiac surgery. J Cardiothorac Vasc Anesth 2000,14(6),698-701","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s004010050508","volume":"92","author":"Braak H.","year":"1996","unstructured":"Braak H.; Braak E.; Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogene-sis. Acta Neuropathol 1996,92(2),197-201","journal-title":"Acta Neuropathol"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"eaaq1702","DOI":"10.1126\/sciadv.aaq1702","volume":"4","author":"Crist\u00f3v\u00e3o JS","year":"2018","unstructured":"Crist\u00f3v\u00e3o JS; Morris VK; Cardoso I; Leal SS; Mart\u00ednez J; Botelho HM; The neuronal S100B protein is a calcium-tuned suppressor of amyloid-\u03b2 aggregation. Science advances 2018,4(6),eaaq1702","journal-title":"Science advances"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ceca.2011.06.001","volume":"50","author":"Prosser B.L.","year":"2011","unstructured":"Prosser B.L.; Hern\u00e1ndez-Ochoa E.O.; Schneider M.F.; S100A1 and calmodulin regulation of ryanodine receptor in striated muscle. Cell Calcium 2011,50(4),323-331","journal-title":"Cell Calcium"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ceca.2014.05.002","volume":"56","author":"Afanador L.","year":"2014","unstructured":"Afanador L.; Roltsch E.A.; Holcomb L.; The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer\u2019s disease mouse model. Cell Calcium 2014,56(2),68-80","journal-title":"Cell Calcium"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1326-9-21","volume":"9","author":"Del Prete D.","year":"2014","unstructured":"Del Prete D.; Checler F.; Chami M.; Ryanodine receptors: physiological function and deregulation in Alzheimer disease. Mol Neurodegener 2014,9(1),21","journal-title":"Mol Neurodegener"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"Hooper C.","year":"2008","unstructured":"Hooper C.; Killick R.; Lovestone S.; The GSK3 hypothesis of Alzheimer\u2019s disease. J Neurochem 2008,104(6),1433-1439","journal-title":"J Neurochem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0968-0004(96)80167-8","volume":"21","author":"Sch\u00e4fer B.W.","year":"1996","unstructured":"Sch\u00e4fer B.W.; Heizmann C.W.; The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996,21(4),134-140","journal-title":"Trends Biochem Sci"},{"key":"ref=85","first-page":"264","volume":"1498","author":"Hoyaux D.","year":"2000","unstructured":"Hoyaux D.; Alao J.; Fuchs J.; Kiss R.; Keller B.; Heizmann C.W.; S100A6, a calcium-and zinc-binding protein, is overexpressed in SOD1 mutant mice, a model for amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA)-. Molecular Cell Research 2000,1498(2-3),264-272","journal-title":"Molecular Cell Research"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"I17","DOI":"10.1007\/BF03161151","volume":"247","author":"Shaw P.","year":"2000","unstructured":"Shaw P.; Eggett C.J.; Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 2000,247(Suppl. 1),I17-I27","journal-title":"J Neurol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/0896-6273(95)90259-7","volume":"14","author":"Wong P.C.","year":"1995","unstructured":"Wong P.C.; Pardo C.A.; Borchelt D.R.; An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995,14(6),1105-1116","journal-title":"Neuron"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","volume":"18","author":"Bruijn L.I.","year":"1997","unstructured":"Bruijn L.I.; Becher M.W.; Lee M.K.; ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997,18(2),327-338","journal-title":"Neuron"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.3390\/ijms21113979","volume":"21","author":"Filipek A.","year":"2020","unstructured":"Filipek A.; Le\u015bniak W.; S100A6 and its brain ligands in neurodegenerative disorders. Int J Mol Sci 2020,21(11),3979","journal-title":"Int J Mol Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3233\/JAD-2010-1303","volume":"19","author":"Mueller C.","year":"2010","unstructured":"Mueller C.; Zhou W.; VanMeter A.; The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer\u2019s disease. J Alzheimers Dis 2010,19(3),1081-1091","journal-title":"J Alzheimers Dis"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JAD-160913","volume":"56","author":"Shen L.","year":"2017","unstructured":"Shen L.; Liao L.; Chen C.; Proteomics analysis of blood serums from alzheimer\u2019s disease patients using itraq labeling technology. J Alzheimers Dis 2017,56(1),361-378","journal-title":"J Alzheimers Dis"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.neurobiolaging.2005.09.033","volume":"27","author":"Shepherd C.E.","year":"2006","unstructured":"Shepherd C.E.; Goyette J.; Utter V.; Inflammatory S100A9 and S100A12 proteins in Alzheimer\u2019s disease. Neurobiol Aging 2006,27(11),1554-1563","journal-title":"Neurobiol Aging"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"17824","DOI":"10.1523\/JNEUROSCI.1504-12.2012","volume":"32","author":"Kummer M.P.","year":"2012","unstructured":"Kummer M.P.; Vogl T.; Axt D.; Mrp14 deficiency ameliorates amyloid \u03b2 burden by increasing microglial phagocytosis and modula-tion of amyloid precursor protein processing. J Neurosci 2012,32(49),17824-17829","journal-title":"J Neurosci"},{"key":"ref=94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032953","volume":"7","author":"Zhang C.","year":"2012","unstructured":"Zhang C.; Liu Y.; Gilthorpe J.; van der Maarel J.R.C.; MRP14 (S100A9) protein interacts with Alzheimer beta-amyloid peptide and induces its fibrillization. PLoS One 2012,7(3)","journal-title":"PLoS One"},{"key":"ref=95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008840","volume":"5","author":"Ha T.Y.","year":"2010","unstructured":"Ha T.Y.; Chang K.A.; Kim J.; S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS One 2010,5(1)","journal-title":"PLoS One"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1189\/jlb.3MR0416-204R","volume":"101","author":"Venegas C.","year":"2017","unstructured":"Venegas C.; Heneka M.T.; Danger-associated molecular patterns in Alzheimer\u2019s disease. J Leukoc Biol 2017,101(1),87-98","journal-title":"J Leukoc Biol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.4103\/1673-5374.145362","volume":"9","author":"Xu Y.","year":"2014","unstructured":"Xu Y.; Li G.; Chen H.; Cheng L.; Zhao R.; Zhao J.; Amyloid precursor-like protein 2 C-terminal fragments upregulate S100A9 gene and protein expression in BV2 cells. Neural Regen Res 2014,9(21),1923-1928","journal-title":"Neural Regen Res"},{"key":"ref=98","first-page":"100","volume":"1835","author":"Markowitz J.","year":"2013","unstructured":"Markowitz J.; Carson W.E.; Review of S100A9 biology and its role in cancer. Biochim Biophys Acta 2013,1835(1),100-109","journal-title":"Biochim Biophys Acta"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1471-4906(03)00062-0","volume":"24","author":"Roth J.","year":"2003","unstructured":"Roth J.; Vogl T.; Sorg C.; Sunderk\u00f6tter C.; Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003,24(4),155-158","journal-title":"Trends Immunol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1021\/acschemneuro.5b00265","volume":"7","author":"Horvath I.","year":"2016","unstructured":"Horvath I.; Jia X.; Johansson P.; Pro-inflammatory s100a9 protein as a robust biomarker differentiating early stages of cognitive impairment in Alzheimer\u2019s Disease. ACS Chem Neurosci 2016,7(1),34-39","journal-title":"ACS Chem Neurosci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1242\/jcs.91.2.221","volume":"91","author":"Wilkinson M.M.","year":"1988","unstructured":"Wilkinson M.M.; Busuttil A.; Hayward C.; Brock D.J.; Dorin J.R.; Van Heyningen V.; Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues. J Cell Sci 1988,91(2),221-230","journal-title":"J Cell Sci"},{"key":"ref=102","first-page":"2162-74","volume":"5","author":"Potts BC","year":"1996","unstructured":"Potts BC; Carlstr\u00f6m G; Okazaki K; Hidaka H; Chazin WJ; 1H NMR assignments of apo calcyclin and comparative structural analysis with calbindin D9k and S100 beta. Protein science : a publication of the Protein Society 1996,5(11),2162-74"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1742-4658.2009.06912.x","volume":"276","author":"Botelho H.M.","year":"2009","unstructured":"Botelho H.M.; Koch M.; Fritz G.; Gomes C.M.; Metal ions modulate the folding and stability of the tumor suppressor protein S100A2. FEBS J 2009,276(6),1776-1786","journal-title":"FEBS J"},{"key":"ref=104","first-page":"383-97","volume":"11","author":"Heizmann CW","year":"1998","unstructured":"Heizmann CW; Cox JA; New perspectives on S100 proteins: a multi-functional Ca(2+)-, Zn(2+)- and Cu(2+)-binding protein family. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 1998,11(4),383-97"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/0140-6736(90)93237-J","volume":"336","author":"Steinbakk M.","year":"1990","unstructured":"Steinbakk M.; Naess-Andresen C-F.; Fagerhol M.K.; Lingaas E.; Dale I.; Brandtzaeg P.; Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990,336(8718),763-765","journal-title":"Lancet"},{"key":"ref=106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005562","volume":"4","author":"Yanamandra K.","year":"2009","unstructured":"Yanamandra K.; Alexeyev O.; Zamotin V.; Amyloid formation by the pro-inflammatory S100A8\/A9 proteins in the ageing prostate. PLoS One 2009,4(5)","journal-title":"PLoS One"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0006-8993(00)02393-3","volume":"867","author":"Hoyaux D.","year":"2000","unstructured":"Hoyaux D.; Decaestecker C.; Heizmann C.W.; S100 proteins in Corpora amylacea from normal human brain. Brain Res 2000,867(1-2),280-288","journal-title":"Brain Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejso.2007.04.009","volume":"34","author":"Salama I.","year":"2008","unstructured":"Salama I.; Malone P.S.; Mihaimeed F.; Jones J.L.; A review of the S100 proteins in cancer. Eur J Surg Oncol 2008,34(4),357-364","journal-title":"Eur J Surg Oncol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1136\/ard.2007.077800","volume":"67","author":"van Lent P.L.E.M.","year":"2008","unstructured":"van Lent P.L.E.M.; Grevers L.; Blom A.B.; Myeloid-related proteins S100A8\/S100A9 regulate joint inflammation and cartilage destruc-tion during antigen-induced arthritis. Ann Rheum Dis 2008,67(12),1750-1758","journal-title":"Ann Rheum Dis"},{"key":"ref=110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118677","volume":"1867","author":"Gonzalez L.L.","year":"2020","unstructured":"Gonzalez L.L.; Garrie K.; Turner M.D.; Role of S100 proteins in health and disease. Biochim Biophys Acta Mol Cell Res 2020,1867(6)","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3390\/ijms13032893","volume":"13","author":"Vogl T.","year":"2012","unstructured":"Vogl T.; Gharibyan A.L.; Morozova-Roche L.A.; Pro-inflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexes. Int J Mol Sci 2012,13(3),2893-2917","journal-title":"Int J Mol Sci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1326-2-18","volume":"2","author":"Kayed R.","year":"2007","unstructured":"Kayed R.; Head E.; Sarsoza F.; Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2007,2(1),18","journal-title":"Mol Neurodegener"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"Wang S.","year":"2018","unstructured":"Wang S.; Song R.; Wang Z.; Jing Z.; Wang S.; Ma J.; S100A8\/A9 in Inflammation. Front Immunol 2018,9,1298","journal-title":"Front Immunol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"35507","DOI":"10.1074\/jbc.M806948200","volume":"283","author":"Zhang L.","year":"2008","unstructured":"Zhang L.; Bukulin M.; Kojro E.; Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metal-loproteinases. J Biol Chem 2008,283(51),35507-35516","journal-title":"J Biol Chem"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.neurobiolaging.2008.05.017","volume":"31","author":"Bianchi R.","year":"2010","unstructured":"Bianchi R.; Giambanco I.; Donato R.; S100B\/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol Aging 2010,31(4),665-677","journal-title":"Neurobiol Aging"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/j.cellsig.2014.06.007","volume":"26","author":"Yang W.","year":"2014","unstructured":"Yang W.; Nam K.; Ju J.; Lee K.; Oh S.; Shin I.; S100A4 negatively regulates \u03b2-catenin by inducing the Egr-1-PTEN-Akt-GSK3\u03b2 degradation pathway. Cell Signal 2014,26(10),2096-2106","journal-title":"Cell Signal"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-18-1232","volume":"25","author":"Park S.Y.","year":"2019","unstructured":"Park S.Y.; Kim J.Y.; Choi J.H.; Inhibition of LEF1-Mediated DCLK1 by niclosamide attenuates colorectal cancer stemness. Clin Cancer Res 2019,25(4),1415-1429","journal-title":"Clin Cancer Res"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s12551-018-0471-y","volume":"10","author":"Bresnick A.R.","year":"2018","unstructured":"Bresnick A.R.; S100 proteins as therapeutic targets. Biophys Rev 2018,10(6),1617-1629","journal-title":"Biophys Rev"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2018.07.034","volume":"439","author":"Gao H.","year":"2018","unstructured":"Gao H.; Zhang I.Y.; Zhang L.; S100B suppression alters polarization of infiltrating myeloid-derived cells in gliomas and inhibits tu-mor growth. Cancer Lett 2018,439,91-100","journal-title":"Cancer Lett"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1073\/pnas.0913660107","volume":"107","author":"Malashkevich V.N.","year":"2010","unstructured":"Malashkevich V.N.; Dulyaninova N.G.; Ramagopal U.A.; Phenothiazines inhibit S100A4 function by inducing protein oligomerization. Proc Natl Acad Sci 2010,107(19),8605-8610","journal-title":"Proc Natl Acad Sci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1172\/JCI200114002","volume":"108","author":"Schmidt A.M.","year":"2001","unstructured":"Schmidt A.M.; Yan S.D.; Yan S.F.; Stern D.M.; The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001,108(7),949-955","journal-title":"J Clin Invest"},{"key":"ref=122","first-page":"2639-49","volume":"23","author":"Cho H","year":"2009","unstructured":"Cho H; Son S; Jin S; Hong H; Shin D; Kim S; RAGE regulates BACE1 and A\u03b2 generation via NFAT1 activation in Alzheimer's dis-ease animal model 2009,23(8),2639-49","journal-title":"RAGE regulates BACE1 and A\u03b2 generation via NFAT1 activation in Alzheimer's dis-ease animal model"},{"key":"ref=123","first-page":"460-74","volume":"118","author":"Salminen A","year":"2011","unstructured":"Salminen A; Kaarniranta K; Haapasalo A; Soininen H.; AMP\u2010activated protein kinase: a potential player in Alzheimer\u2019s disease 2011,118(4),460-74","journal-title":"AMP\u2010activated protein kinase: a potential player in Alzheimer\u2019s disease"},{"key":"ref=124","first-page":"1006. e11","volume":"33","author":"Son SM","year":"2012","unstructured":"Son SM; Jung ES; Shin HJ; Byun J; A\u03b2-induced formation of autophagosomes is mediated by RAGE-CaMKK\u03b2-AMPK signaling 2012,33(5),1006. e11","journal-title":"A\u03b2-induced formation of autophagosomes is mediated by RAGE-CaMKK\u03b2-AMPK signaling"},{"key":"ref=125","first-page":"1400-0","volume":"33","author":"Li XH","year":"2012","unstructured":"Li XH; Lv BL; Xie JZ; Liu J; Zhou XW; AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation 2012,33(7),1400-0","journal-title":"AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"42-51","DOI":"10.1097\/01.jnen.0000199599.63204.6f","volume":"65","author":"Webster B","year":"2006","unstructured":"Webster B; Hansen L; Adame A; Crews L; Torrance M; Thal L; Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease 2006,65(2),42-51","journal-title":"Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"9120","DOI":"10.1021\/jm300172z","volume":"55","author":"Han Y.T.","year":"2012","unstructured":"Han Y.T.; Choi G.I.; Son D.; Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of re-ceptor for advanced glycation end products (RAGE) inhibitors. J Med Chem 2012,55(21),9120-9135","journal-title":"J Med Chem"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2014.03.072","volume":"79","author":"Han Y.T.","year":"2014","unstructured":"Han Y.T.; Kim K.; Choi G.I.; Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE). Eur J Med Chem 2014,79,128-142","journal-title":"Eur J Med Chem"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.bmc.2015.05.022","volume":"23","author":"Choi K.","year":"2015","unstructured":"Choi K.; Lim K.S.; Shin J.; 6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE). Bioorg Med Chem 2015,23(15),4919-4935","journal-title":"Bioorg Med Chem"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0006-291X(90)91544-3","volume":"172","author":"Herbert J.","year":"1990","unstructured":"Herbert J.; Augereau J.; Gleye J.; Maffrand J.J.B.; Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990,172(3),993","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"Koppaka V.","year":"2012","unstructured":"Koppaka V.; Thompson D.C.; Chen Y.; Ellermann M.; Nicolaou K.C.; Juvonen R.O.; Aldehyde dehydrogenase inhibitors: a comprehen-sive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev 2012,64(3),520-539","journal-title":"Pharmacol Rev"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1021\/acs.biochem.8b00204","volume":"57","author":"Palanski B.A.","year":"2018","unstructured":"Palanski B.A.; Khosla C.J.B.; Cystamine and disulfiram inhibit human transglutaminase 2 via an oxidative mechanism. Biochemistry 2018,57(24),3359-3363","journal-title":"Biochemistry"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/508342","volume":"2015","author":"Cirillo C.","year":"2015","unstructured":"Cirillo C.; Capoccia E.; Iuvone T.; S100B inhibitor pentamidine attenuates reactive gliosis and reduces neuronal loss in a mouse model of Alzheimer\u2019s Disease. BioMed Res Int 2015,2015,1-11","journal-title":"BioMed Res Int"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/cmdc.200900393","volume":"5","author":"Agamennone M.","year":"2010","unstructured":"Agamennone M.; Cesari L.; Lalli D.; Fragmenting the S100B-p53 interaction: combined virtual\/biophysical screening approaches to identify ligands. ChemMedChem 2010,5(3),428-435","journal-title":"ChemMedChem"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1021\/bi5005552","volume":"53","author":"Cavalier M.C.","year":"2014","unstructured":"Cavalier M.C.; Pierce A.D.; Wilder P.T.; Alasady M.J.; Hartman K.G.; Neau D.B.; Covalent small molecule inhibitors of ca2+-bound s100b. Biochemistry 2014,53(42),6628-6640","journal-title":"Biochemistry"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1021\/bi9019077","volume":"49","author":"Rani S.G.","year":"2010","unstructured":"Rani S.G.; Mohan S.K.; Yu C.J.B.; Molecular level interactions of S100A13 with amlexanox: inhibitor for formation of the multiprotein com-plex in the nonclassical pathway of acidic fibroblast growth factor. Biochemistry 2010,49(11),2585-2592","journal-title":"Biochemistry"},{"key":"ref=137","first-page":"109","volume":"2010","author":"Wilder P.T.","year":"2010","unstructured":"Wilder P.T.; Charpentier T.H.; Liriano M.A.; Gianni K.; Varney K.M.; Pozharski E.; In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction. Int J High Throughput Screen 2010,2010(1),109","journal-title":"Int J High Throughput Screen"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jmb.2008.06.047","volume":"382","author":"Charpentier T.H.","year":"2008","unstructured":"Charpentier T.H.; Wilder P.T.; Liriano M.A.; Divalent metal ion complexes of S100B in the absence and presence of pentamidine. J Molecul Biol 2008,382(1),56-73","journal-title":"J Molecul Biol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neulet.2003.09.018","volume":"353","author":"S\u00fcssmuth S.D.","year":"2003","unstructured":"S\u00fcssmuth S.D.; Tumani H.; Ecker D.; Ludolph A.C.; Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Neurosci Lett 2003,353(1),57-60","journal-title":"Neurosci Lett"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.prp.2018.11.011","volume":"215","author":"Chen L.","year":"2019","unstructured":"Chen L.; Hu X.; Wu H.; Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value. Pathol Res Pract 2019,215(3),427-432","journal-title":"Pathol Res Pract"},{"key":"ref=141","first-page":"138","volume":"3","author":"Wright N.T.","year":"2009","unstructured":"Wright N.T.; Cannon B.R.; Zimmer D.B.; Weber D.J.; S100A1: Structure, Function, and Therapeutic Potential. Curr Chem Biol 2009,3(2),138-145","journal-title":"Curr Chem Biol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"756","DOI":"10.14336\/AD.2018.0912","volume":"10","author":"Tian Z.Y.","year":"2019","unstructured":"Tian Z.Y.; Wang C.Y.; Wang T.; Li Y.C.; Wang Z.Y.; Glial S100A6 Degrades \u03b2-amyloid aggregation through targeting competition with zinc ions. Aging Dis 2019,10(4),756-769","journal-title":"Aging Dis"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.molmed.2011.01.005","volume":"17","author":"Masters S.L.","year":"2011","unstructured":"Masters S.L.; O\u2019Neill L.A.J.; Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. Trends Mol Med 2011,17(5),276-282","journal-title":"Trends Mol Med"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.neurobiolaging.2012.11.007","volume":"34","author":"Wasik U.","year":"2013","unstructured":"Wasik U.; Schneider G.; Mietelska-Porowska A.; Calcyclin binding protein and Siah-1 interacting protein in Alzheimer\u2019s disease pathology: neuronal localization and possible function. Neurobiol Aging 2013,34(5),1380-1388","journal-title":"Neurobiol Aging"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527322666221128160653","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211317\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871527322666221128160653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T03:49:06Z","timestamp":1701488946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211317\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":144,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527322666221128160653","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}